Deutsche Bank’s Regulus Therapeutics RGLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,252
| Closed | -$3.94K | – | 3715 |
|
|
2025
Q1 | $3.94K | Buy |
+2,252
| New | +$2.97K | ﹤0.01% | 3528 |
|
|
2018
Q2 | – | Sell |
-1
| Closed | – | – | 5580 |
|
|
2018
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 5572 |
|
|
2017
Q4 | $0 | Sell |
1
-4,291
| -100% | -$543K | ﹤0.01% | 5110 |
|
|
2017
Q3 | $643K | Buy |
4,292
+4,291
| +429,100% | +$540K | ﹤0.01% | 3286 |
|
|
2017
Q2 | $0 | Sell |
1
-437
| -100% | -$72.9K | ﹤0.01% | 5083 |
|
|
2017
Q1 | $85K | Sell |
438
-1,378
| -76% | -$262K | ﹤0.01% | 3996 |
|
|
2016
Q4 | $489K | Sell |
1,816
-1,179
| -39% | -$383K | ﹤0.01% | 3183 |
|
|
2016
Q3 | $1.19M | Buy |
2,995
+2,127
| +245% | +$875K | ﹤0.01% | 2718 |
|
|
2016
Q2 | $299K | Buy |
868
+261
| +43% | +$187K | ﹤0.01% | 3552 |
|
|
2016
Q1 | $503K | Buy |
607
+24
| +4% | +$19.1K | ﹤0.01% | 3212 |
|
|
2015
Q4 | $608K | Sell |
583
-14
| -2% | -$14K | ﹤0.01% | 3179 |
|
|
2015
Q3 | $467K | Sell |
597
-572
| -49% | -$587K | ﹤0.01% | 3391 |
|
|
2015
Q2 | $1.53M | Buy |
1,169
+297
| +34% | +$479K | ﹤0.01% | 2678 |
|
|
2015
Q1 | $1.77M | Buy |
872
+352
| +68% | +$765K | ﹤0.01% | 2526 |
|
|
2014
Q4 | $999K | Buy |
520
+399
| +330% | +$710K | ﹤0.01% | 3208 |
|
|
2014
Q3 | $98K | Sell |
121
-17
| -12% | -$14.4K | ﹤0.01% | 4513 |
|
|
2014
Q2 | $132K | Sell |
138
-39
| -22% | -$33.4K | ﹤0.01% | 4396 |
|
|
2014
Q1 | $190K | Sell |
177
-6
| -3% | -$6.65K | ﹤0.01% | 3919 |
|
|
2013
Q4 | $162K | Buy |
183
+78
| +74% | +$67.2K | ﹤0.01% | 3803 |
|
|
2013
Q3 | $118K | Buy |
105
+23
| +28% | +$27.1K | ﹤0.01% | 4365 |
|
|
2013
Q2 | $95K | Buy |
+82
| New | +$78K | ﹤0.01% | 4255 |
|
Other funds holding RGLS
Deutsche Bank's RGLS Position: Q2 2025 in Review
Deutsche Bank sold out of Regulus Therapeutics (RGLS) in Q2 2025, closing a stake of 2,252 shares — an estimated $3.94K sold.
Deutsche Bank first reported a position in RGLS in Q2 2013 and held it in 21 quarters. The position peaked at $1.77M in Q1 2015. 0 funds tracked by Wall St. Rank hold RGLS as of Q2 2025.
- Deutsche Bank reported no remaining Regulus Therapeutics position as of Q2 2025 after selling out during the quarter.
- Deutsche Bank sold 2,252 Regulus Therapeutics shares in Q2 2025, an estimated $3.94K.
- Deutsche Bank first reported a position in Regulus Therapeutics in Q2 2013 and held it in 21 quarters.
- Deutsche Bank's Regulus Therapeutics position peaked at $1.77M in Q1 2015.
- 0 funds tracked by Wall St. Rank held Regulus Therapeutics as of Q2 2025.
Based on Deutsche Bank's 13F filing for Q2 2025, filed 12 Aug 2025.